blood plasma

Sinovac to invest Tk5,000cr in plasma-based medicines
Health

Sinovac to invest Tk5,000cr in plasma-based medicines

An apheresis machine separates and collects convalescent plasma from the whole blood of a recovered coronavirus (Covid-19) patient at the Central Seattle Donor Center of Bloodworks Northwest during the outbreak in Seattle, Washington, US April 17, 2020. The plasma from recovered patients will be used in an experimental treatment study for current coronavirus patients/ Reuters
Coronavirus chronicle

US FDA authorises use of blood plasma to treat coronavirus